Biomarker ID | 1039 |
PMID | 23322201 |
Year | 2013 |
Biomarker | Alanyl membrane aminopeptidase (ANPEP) |
Biomarker Basis | Methylation Based |
Biomolecule | Methylation |
Source | Tissue |
Subjects | Humans |
Regulation | Hypermethylated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways include: Renin-angiotensin system, SARS coronavirus protease, Dendritic cells in regulating TH1 and TH2 development, Glutathione metabolism, C-Myb transcription factor network |
Experiment | Prostate Cancer Vs Non Malignant Tissue |
Type of Biomarker | Diagnostic |
Cohort | 248 Non Malignant and PCa tissue samples were used for the study. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.0025 |
Method Used | quantitative methylation-specific PCR assay |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |